Unihealth Hospitals Ltd Q2 FY26 Results & Concall Highlights: Revenue, Margins & Order Book
Published 26 Aug 2026 | Healthcare Services | Market Cap: ₹1.1K Cr
UniHealth plans a significant multi-pronged expansion over 5-7 years, targeting greenfield projects, acquisitions, and operational management outsourcing. UniHealth plans multi-pronged expansion via greenfield projects, acquisitions, and O&M, targeting 1,000 beds by FY 27-28.
From Unihealth Hospitals Ltd's Q2 FY26 earnings-call transcript · updated 26 Aug 2026.
Price
₹706
Market Cap
₹1.1K Cr
P/E Ratio
41.9
How does Unihealth Hospitals Ltd rank in Healthcare Services?
Compare Unihealth Hospitals Ltd against every Healthcare Services company this quarter on revenue, margins and earnings-call signals.
📊 Revenue & Sales Performance
- →UniHealth plans a significant multi-pronged expansion over 5-7 years, targeting greenfield projects, acquisitions, and operational management outsourcing.
- →FY 27-28 target: achieve 1,000 beds.
- →Revenue contribution from Uganda is currently 90%, expected to drop to 50-60% by end of FY 27-28, with India contributing 40-50%; Tanzania to add revenue in coming years.
- →Navi Mumbai and Nashik hospitals (India) expected to contribute ~INR125 crore revenue next financial year.
- →Navi Mumbai (52 beds) aims for 60-70% occupancy in FY 27; Nashik (200 beds) to reach ~50% occupancy by Q2 FY 28.
- →Average revenue per occupied bed in India expected to scale from INR27,000-28,000 to INR55,000-60,000 over 3-5 years.
- →Consultancy projects pipeline at 600-650 beds, awaiting financial closure.
- →Uganda facility continues growth, adding ophthalmology soon, with stable revenues.
📈 Profitability & Margins
- →UniHealth plans multi-pronged expansion via greenfield projects, acquisitions, and O&M, targeting 1,000 beds by FY 27-28.
- →Indian hospitals (Navi Mumbai and Nashik) will contribute significantly, aiming combined revenue of INR 125+ crores in next financial year.
- →Uganda currently contributes ~90% revenue; expected to reduce to 50%-60% by end of next financial year as India and Tanzania ramp up.
- →EBITDA margins for Indian hospitals expected between 15%-18% in the first year, with Navi Mumbai potentially reaching 20%-25%.
- →Mature units like Uganda maintain stable EBITDA margins; new facilities' margins may be pressured initially but improve post-break-even in 18-24 months.
- →Consultancy services pipeline includes 600-650 beds in early discussions but timelines for revenue addition uncertain (3-6 months or more).
- →Expected sustainable tax benefits from Uganda tax holiday until 2034 support profitability.
- →Scalability and margin improvements anticipated over medium term with growth in India and Africa operations.
🏗️ Capital Expenditure Plans
- →Navi Mumbai capex completed using IPO proceeds from 2023.
- →Nashik financial closure achieved via equity and bank debt (INR 22 crores from Bank of India).
- →20-bedded secondary care center in Tanzania achieved financial closure with internal equity approvals.
- →Planned 100-bedded tertiary care hospital in Tanzania under final discussion; funding needed.
- →Pune has a multi-pronged expansion plan including greenfield projects, operational acquisitions, or O&M models.
- →Target to achieve 1,000 operational beds across India and Africa by FY 2027-28.
- →Future projects like Pune and the 100-bed Tanzania facility will require a mix of internal accruals, bank debt, and possibly capital leasing.
- →Uganda is now debt-free; its cash flows to support expansion funding.
- →Strategy includes asset-light models with long-term leases for Indian hospitals (Navi Mumbai, Nashik).
💰 Fundraising & Capital Structure
- →Navi Mumbai project capex was funded via proceeds from the 2023 IPO.
- →Nashik project achieved financial closure through equity contribution and a sanctioned bank debt of INR 22 crores from Bank of India, partly funded by promoter warrants.
- →The 20-bedded secondary care centre in Tanzania has also achieved financial closure through internal approvals and equity contribution.
- →Future projects such as the 100-bedded facility in Tanzania and Pune will require additional funding.
- →Funding for these upcoming projects is expected to come partly from internal accruals and cash flows rerouted from Uganda, which is now debt-free.
- →The company is open to availing bank debt for Tanzania and may explore capital leasing.
- →Final funding decisions for Tanzania's 100-bed facility and Pune projects will be made at the time of project closure, considering both debt and equity options.
📋 Order Book & Pipeline
- →Currently, UniHealth Hospitals is handling about 1,300 beds on a consolidated basis in consultancy projects, which has been stable over the last 12+ months.
- →They have completed some smaller consultancy projects recently and added a couple of new ones.
- →There are ongoing discussions for consultancy projects involving an additional 600-650 beds in total.
- →These discussions are in initial stages, pending financial closure by the investors before formal agreements.
- →UniHealth is a shortlisted consultant for these projects, but no formal contracts have yet been signed.
- →Project cycles from initial consultancy to completion typically take 2 to 5 years.
- →Revenue from consultancy is based on milestones over the timeline.
- →Hence, pending orders mainly relate to these potential projects in early-stage discussion without finalized contracts.
Key Metrics
Frequently Asked Questions
What were Unihealth Hospitals Ltd Q2 FY26 results?
UniHealth plans a significant multi-pronged expansion over 5-7 years, targeting greenfield projects, acquisitions, and operational management outsourcing. UniHealth plans multi-pronged expansion via greenfield projects, acquisitions, and O&M, targeting 1,000 beds by FY 27-28.
What is Unihealth Hospitals Ltd share price analysis?
Unihealth Hospitals Ltd currently shows a neutral. The stock trades at a P/E of 41.9 with a market cap of ₹1,075 Cr. Investors should review the full earnings analysis for detailed insights.
Is Unihealth Hospitals Ltd planning capital expenditure?
Navi Mumbai capex completed using IPO proceeds from 2023.
Keep Unihealth Hospitals Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.